Federal health officials are warning doctors and patients that a counterfeit version of Botox has made its way into the U.S. market.
The FDA says the fake drug may have been sold to medical practices nationwide by a supplier who was not authorized to distribute pharmaceuticals in this country.
Officials say the fake Botox can be spotted by one or more of these errors on the label:
-- the vial is missing the lot number
-- the outer carton does not have any entries next to the LOT: MFG: EXP:
-- the outer carton and vial display the active ingredient as "Botulinum Toxin Type A" instead of "OnabotulinumtoxinA"
More: Read more at CBSNews.com
